Tylan 200 injection recalled owing to sterility concerns
A product recall alert has been issued for Tylan 200 mg/ml Solution for Injection.
A product recall alert has been issued for Tylan 200 mg/ml Solution for Injection owing to concern about the product’s sterility.
The Veterinary Medicines Directorate (VMD) writes: ‘We wish to make wholesalers and veterinary surgeons aware that Elanco UK AH Ltd has issued a recall of Tylan 200mg/ml Solution for Injection (Vm 00006/4098) due to a failed periodic revalidation (media fill test) that may affect the level of sterility assurance of certain products.’
The recall affects batch no. C967336A, expiry date 07/2020. Elanco is in the process of contacting wholesalers and veterinary surgeons urging them to examine their inventory immediately and quarantine affected products.
The VMD continues: ‘This issue only applies to the batch listed above. Any other batches of Tylan 200 Injection are not impacted and may continue to be distributed. For further information regarding the recall, please contact Ms Victoria Haslingden 01256 779519 or email elanco_orders@lilly.com’
BSAVA is to partner with BVA Live (11-12 June 2026) to champion clinical research.
